Our study’s primary aim was to evaluate the association of common putatively functional SNPs in HRR genes NBN, RAD51, and XRCC3 with RT adverse events in patients with early HER2-positive breast cancer treated with adjuvant RT. This evidence concerns the gene XRCC3 and breast cancer.